JPH01168660A - Yl-0710m compound and production thereof - Google Patents

Yl-0710m compound and production thereof

Info

Publication number
JPH01168660A
JPH01168660A JP32764487A JP32764487A JPH01168660A JP H01168660 A JPH01168660 A JP H01168660A JP 32764487 A JP32764487 A JP 32764487A JP 32764487 A JP32764487 A JP 32764487A JP H01168660 A JPH01168660 A JP H01168660A
Authority
JP
Japan
Prior art keywords
compound
culture
formula
strain
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP32764487A
Other languages
Japanese (ja)
Inventor
Mikio Morioka
幹夫 森岡
Kenichi Suzuki
賢一 鈴木
Koji Nagai
浩二 永井
Shigeru Miyazaki
宮崎 繁
Chieko Nohara
野原 智恵子
Noribumi Hashimoto
橋本 則文
Takeshi Saito
武 斎藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Priority to JP32764487A priority Critical patent/JPH01168660A/en
Publication of JPH01168660A publication Critical patent/JPH01168660A/en
Pending legal-status Critical Current

Links

Abstract

NEW MATERIAL:The YL-0710M compound of formula having the following properties. Appearance, pale-yellow amorphous solid; nature, basic; solubility, soluble in methanol, ethanol, acetone, ethyl acetate, butyl acetate, benzene, toluene and chloroform, scarcely soluble in water and almost insoluble in hexane; molecular weight, 573[M+1] and 595[M+Na] (by FAB-Mass); molecular formula, C29H40N4O8. USE:An antibacterial agent and antitumor agent. It exhibits excellent action especially against Gram-positive bacteria and strong cytotoxic action against various tumor cells. PREPARATION:The objective compound of formula can be produced by culturing YL-0710M strain (FERM P-9728) belonging to Streptomyces genus and capable of producing YL-0710M compound under aerobic condition and subjecting the cultured product to extraction, separation and purification.

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は、抗菌作用および細胞障害作用を有する新規な
YL−0710M化合物およびその製造法に関する。
DETAILED DESCRIPTION OF THE INVENTION (Field of Industrial Application) The present invention relates to a novel YL-0710M compound having antibacterial and cytotoxic effects and a method for producing the same.

(発明が解決しようとする問題点、解決するための手段
) 本発明の化合物は、下記の平面化学構造式で示されるY
L−0710M化合物である。
(Problems to be solved by the invention, means for solving them) The compound of the present invention has the following planar chemical structural formula:
This is the L-0710M compound.

また9本発明の製造法は、ストレプトミセス属に属する
YL−0710M化合物生産菌を培養し。
Further, in the production method of the present invention, YL-0710M compound-producing bacteria belonging to the genus Streptomyces are cultured.

培養物からYL−0710M化合物を採取することから
なる上記YL −0710M化合物の製造法である。
This is a method for producing the above YL-0710M compound, which comprises collecting the YL-0710M compound from a culture.

(発明の効果) YL −0710M化合物は、各種細菌株にダラム陽性
菌に対し、抗菌作用を示すと共に、各種腫瘍細胞に対し
9強い細胞障害作用を有しているので抗菌剤、抗腫瘍剤
として有用である。
(Effects of the Invention) The YL-0710M compound exhibits antibacterial activity against various bacterial strains and Durham-positive bacteria, and also has a strong cytotoxic effect against various tumor cells, so it can be used as an antibacterial agent and an antitumor agent. Useful.

(1)抗菌作用 各種細菌に対するYL −0710M化合物の最少発育
阻止濃度(MIC)を表1に示す。
(1) Antibacterial effect Table 1 shows the minimum inhibitory concentration (MIC) of the YL-0710M compound against various bacteria.

(2)腫瘍細胞を用いる試験管内細胞障害作用試験方法
: 1 x 10’ cells/mtに調整したL121
0”、 P2S5”の各細胞液1 mlに、エタノール
で溶解した各濃度のYL −0710M化合物4μtを
加え。
(2) In vitro cytotoxicity test method using tumor cells: L121 adjusted to 1 x 10' cells/mt
4 μt of YL-0710M compound at each concentration dissolved in ethanol was added to 1 ml of each cell suspension of 0'' and P2S5''.

37℃炭酸ガス培養器中で3日間培養した後。After culturing for 3 days in a carbon dioxide incubator at 37°C.

トリバンプルー染色法により生残細胞を計数した。細胞
障害活性は、薬剤無添加の細胞数を対照として各濃度で
の細胞増殖抑制率を算出し、グラフ上にプロットして求
めた。
Surviving cells were counted by Trivan blue staining method. Cytotoxic activity was determined by calculating the cell proliferation inhibition rate at each concentration using the number of cells without the addition of the drug as a control, and plotting the results on a graph.

使用したmedium : It  RPMI −1640+ 10%新生子牛血清
mW  RPMI −1640+ 5%牛脂児血清+5
μM2−ヒドロキシエチル ジスルーフイド表2 (製造法) YL−0710M化合物は、ストレプトミセス属にに属
するYL−0710M化合物生産菌を培養し、培養物か
らYL−0710M化合物を採取することにより製造す
ることができる。
Medium used: It RPMI-1640+ 10% newborn calf serum mW RPMI-1640+ 5% beef tallow serum +5
μM2-hydroxyethyl disulfide Table 2 (Production method) The YL-0710M compound can be produced by culturing a YL-0710M compound-producing bacterium belonging to the genus Streptomyces and collecting the YL-0710M compound from the culture. .

この製造法で使用するYL −0710M化合物生産菌
の一例としては9本発明者等が沖縄県南大東島より分離
したストレプトミセス ニス・ピー(Streptom
yces sp、)YL−0710M株(微工研菌寄第
9728号)を挙げることができる。この菌株の菌学的
性状を以下に記す。
An example of YL-0710M compound-producing bacteria used in this production method is Streptomyces nisp.
yces sp,) YL-0710M strain (Feikoken Bibori No. 9728). The mycological properties of this strain are described below.

(1)形態 本菌株は各種合成及び有機培地において生育し、特にス
ターチ・無機塩寒天培地、イースト麦芽寒天培地、ペプ
トン・イースト・鉄寒天培地で良好である。気菌糸はス
ターチ・無機塩寒天培地、オートミール寒天培地でよく
着生し、その色調は灰白〜灰色である。光学顕微鏡観察
によれば、気菌糸は単純分枝で。
(1) Morphology This strain grows on various synthetic and organic media, particularly starch/inorganic salt agar, yeast malt agar, and peptone/yeast/iron agar. Aerial mycelium grows well on starch/inorganic salt agar medium and oatmeal agar medium, and its color is grayish-white to gray. According to light microscopy, aerial hyphae are simply branched.

先端が開いたらせん状(0pen 5piral )を
示し。
It shows a spiral shape with an open tip (0pen 5piral).

形状はセクションスピラレス(S)である。電子顕微鏡
での観察で、胞子は50個程度の連鎖を認め、胞子の大
きさは0.5〜0,7 X O,8〜1.0μmであり
、その表面構造はとげ状である。輪生枝、胞子嚢及び菌
核形成は認められない。
The shape is section spirales (S). By observation with an electron microscope, a chain of about 50 spores was observed, the size of the spores was 0.5 to 0.7 x O, 8 to 1.0 μm, and the surface structure was thorn-like. Whorled branches, sporangia, and sclerotia formation are not observed.

(2)各種寒天培地上の性状 各種寒天培地上の性状は、以下に示すとおりである。特
に記載しないかぎり、28℃で21日間培養し、常法に
従って観察したものである。色調の記載については色の
標準(日本色彩研究所)によった。
(2) Properties on various agar media Properties on various agar media are as shown below. Unless otherwise specified, the cells were cultured at 28° C. for 21 days and observed according to conventional methods. The description of color tone was based on the color standard (Japan Color Research Institute).

表3 (3)生理的性質 表4 (注)生育温度は各温度(5,10,15,20,25
,28,30,33゜37.40,45.50℃)で、
7〜21日までの観察結果。
Table 3 (3) Physiological properties Table 4 (Note) The growth temperature is at each temperature (5, 10, 15, 20, 25
,28,30,33°37.40,45.50°C),
Observation results from days 7 to 21.

ミルクに対する作用は37℃で3〜21日までの観察結
果。それ以外は特に指摘のないかぎり28℃で2週間後
の観察結果を示す。
The effect on milk was observed at 37°C for 3 to 21 days. Unless otherwise specified, the results are shown after 2 weeks at 28°C.

(4)  炭素源の資化性 (プリドハム・ゴドリープ寒天培地、28°C培養)表
5 (注)+;生育する 士;生育が疑わしい−;生育しな
い (5)  ジアミノピメリン酸(DAP)の分析LEC
HVALIERらの方法(LECHVALIEI:R,
MP、 et al; PP 277−238 in 
DIETZ、 A et al ed、、 Actin
omyceteTaXOnOmy+ SIM 5pec
ial publication No、6+ 198
0 )に従い9本菌株の酸加水分解物の分析を行った結
果。
(4) Assimilation of carbon sources (Pridham-Godliep agar medium, 28°C culture) Table 5 (Note) +; Growing; Growth questionable -; Not growing (5) Analysis of diaminopimelic acid (DAP) LEC
The method of HVALIER et al. (LECHVALIEI:R,
MP, et al; PP 277-238 in
DIETZ, A et al ed, Actin
omyceteTaXOnOmy+ SIM 5pec
ial publication No. 6+ 198
Results of analysis of acid hydrolysates of nine bacterial strains according to 0).

LL−ジアミノピメリン酸が検出された。LL-diaminopimelic acid was detected.

以上の性状を要約すると、  YL−0710M株は。To summarize the above properties, the YL-0710M strain is.

各種寒天培地上で形成される気菌糸が単純分枝で、その
形状はセクションスピラレス(S)であり、50個程度
の胞子の連鎖が観察される。色相は生育がうす黄茶〜黄
茶、気菌糸が灰白〜灰を呈し、可溶性色素、メラニン様
色素の生成は認められない。また菌体の酸加水分解物の
分析よりLL−ジアミノピメリン酸が検出された。
Aerial hyphae formed on various agar media are simply branched, the shape is section spirales (S), and chains of about 50 spores are observed. As for the hue, the growth is pale yellow-brown to yellow-brown, the aerial mycelia are gray-white to gray, and no production of soluble pigments or melanin-like pigments is observed. Furthermore, LL-diaminopimelic acid was detected by analysis of the acid hydrolyzed product of the bacterial cells.

上記諸性質より2本菌株はストレプトミセス(Stre
ptomyces )属に属する菌株と考えられ9本菌
株に類似する既知菌種を、[バーシーズ・マニュアル・
オプ・デタミネディプ・バクテリオロジー(Berge
y’s Manual of Detaminativ
e Bacteriology )第8版、  197
4年」、[インターナショナル・ジャーナル・オブ・シ
ステマティック・バクテリオロジー(Internat
ional Journal of Systemat
ic Bacteriology )第18巻、2号、
69−189頁、4号、 279−392頁(1968
)、第19巻、4号、  391−512頁(1969
)を第22巻、4号、  265−394頁(1972
) Jより検索した。その結果5本菌株に類似な菌とし
ては、ストレプトミセス オリバセウス(S、 oli
vaceus )とストレフトミセス シオヤネンシス
(S、 5ioyanensis )があげられる。ど
ちらの菌も気菌糸の形状、コロニーの色調、胞子の表面
構造9色素生成の有無などの性状においては本菌株と類
似しているが、炭素源の資化性(表6)及び各種培地上
の気菌糸の色調(表7)においてわずかに異っており9
本菌株と一致しない。以上の結果より本菌株をストレプ
トミセス属に属する新種であると判断し、ストレプトミ
セス ニス・ピー(Strepto−myces sp
、) YL −0710M株と命名した。本菌株は。
Based on the above properties, the two strains are Streptomyces (Streptomyces).
Known bacterial strains similar to the nine strains, which are considered to belong to the genus Ptomyces), were
Op Detaminedip Bacteriology (Berge
y's Manual of Determinative
e Bacteriology) 8th edition, 197
International Journal of Systematic Bacteriology (International Journal of Systematic Bacteriology)
ional Journal of Systemat
ic Bacteriology) Volume 18, No. 2,
pp. 69-189, No. 4, pp. 279-392 (1968
), Volume 19, No. 4, pp. 391-512 (1969
) Vol. 22, No. 4, pp. 265-394 (1972
) Searched from J. As a result, Streptomyces olivaceus (S, oli
vaceus) and Streftomyces ioyanensis (S, 5ioyanensis). Both strains are similar to this strain in terms of properties such as the shape of aerial mycelia, color tone of colonies, and the presence or absence of pigment production on the surface structure of spores, but they are similar to this strain in terms of their ability to assimilate carbon sources (Table 6) and on various media. The color tone of the aerial mycelium (Table 7) differs slightly between 9 and 9.
It does not match this strain. Based on the above results, this strain was determined to be a new species belonging to the genus Streptomyces, and Strepto-myces sp.
) YL-0710M strain. This strain is.

工業技術院微生物工業技術研究所に微工研菌寄第972
8号として寄託されている。
Microbiology Research Institute No. 972 at the Institute of Microbial Technology, Agency of Industrial Science and Technology
It has been deposited as No. 8.

表6  YL−0710Mと類似菌種との比較(炭素源
の資化性)表7  YL−0710Mと類似菌種との比
較(気菌糸の色調)本発明に用いられる菌株は、他の放
線菌にも見られるごとく1人工的にまた自然に変異をお
こしやすいが9本発明のい5 YL−0710M株は天
然から分離された放線菌、あるいはこれを紫外線、X線
、化学薬剤などで人工的に変異させた菌株及びそれらの
自然変異株をも包含するものである。
Table 6 Comparison of YL-0710M with similar bacterial species (carbon source assimilation ability) Table 7 Comparison of YL-0710M with similar bacterial species (color tone of aerial hyphae) The bacterial strains used in the present invention are other actinomycetes As seen in 1, it is easy to cause mutations either artificially or naturally. It also includes bacterial strains that have been mutated and natural mutant strains thereof.

本発明の新菌種に属する微生物は天然の土壌より分離し
て取得したものであるが、前記微生物工業技術研究所に
寄託した菌株の凍結乾燥品を復元することによって容易
に取得することができる。本発明において、スプレブト
ミセス属に属するYL−0710M化合物生産菌の培養
は一般微生物の培養方法に準じておこなわれるが通常は
液体培地による深部培養法が有利である。培養に用いら
れる培地としては、該生産菌が利用する栄養源を含有す
る培地であればよい。すなわち合成培地、半合成培地あ
るいは天然培地が用いられ、培地の組成は、たとえば炭
素源としてはD−キシロース、グルコース、D−フラク
ドース、L−ラムノース、マンニトール、グリセリン、
デキストリン、澱粉、植物油などが。
The microorganisms belonging to the new bacterial species of the present invention were obtained by isolation from natural soil, but they can be easily obtained by restoring the freeze-dried product of the strain deposited with the Microbial Technology Research Institute. . In the present invention, the YL-0710M compound-producing bacteria belonging to the genus Sprebutomyces is cultured according to the culture method of general microorganisms, but the deep culture method using a liquid medium is usually advantageous. The medium used for culturing may be any medium as long as it contains a nutrient source used by the producing bacteria. That is, a synthetic medium, a semi-synthetic medium or a natural medium is used, and the composition of the medium is, for example, carbon sources such as D-xylose, glucose, D-fracdose, L-rhamnose, mannitol, glycerin,
Dextrin, starch, vegetable oil, etc.

窒素源としては肉エキス、ペプトン、グルテンミール、
綿実粕、大豆粉、落花生粉、魚粉、コ′ −ンスチープ
リカー、乾燥酵母、酵母エキス。
Nitrogen sources include meat extract, peptone, gluten meal,
Cottonseed meal, soybean flour, peanut flour, fishmeal, cornsteep liquor, dried yeast, yeast extract.

硫酸アンモニウム、硝酸アンモニウム、尿素その池の有
機または無機の窒素源が用いられる。
Ammonium sulfate, ammonium nitrate, urea and other organic or inorganic nitrogen sources are used.

また金属塩としてNa、 K、 Mg、 Ca、 Zn
、 Feなどの硫酸塩、硝酸塩、塩化物、炭酸塩、燐酸
塩などが必要に応じて添加される。さらに必要に応じて
Also, as metal salts, Na, K, Mg, Ca, Zn
, Fe and other sulfates, nitrates, chlorides, carbonates, phosphates, etc. are added as necessary. More if necessary.

メチオニン、システィン、シスチン、オレイン酸メチル
、ラード油、シリコン油、界面活性剤などの抗生物質生
成促進物質又は消泡剤が適宜使用される。
Antibiotic production accelerators or antifoaming agents such as methionine, cysteine, cystine, methyl oleate, lard oil, silicone oil, and surfactants are used as appropriate.

培養条件としては好気的条件下に培養するのが一般的に
有利で、培養温度は約18〜35℃の範囲が望ましく、
好ましくは約30℃附近が用いられ、培地のpHは約5
〜10.好ましくは約6〜8の範囲に保持すると好結果
が得られる。培養期間は培地の組成、温度などによって
変動するが、一般に1〜5日程度でよく、培養終了時に
目的物質が選択的に蓄積される。
As for the culture conditions, it is generally advantageous to culture under aerobic conditions, and the culture temperature is preferably in the range of about 18 to 35°C.
Preferably, the temperature is around 30°C, and the pH of the medium is around 5.
~10. Good results are obtained by keeping it preferably in the range of about 6-8. The culture period varies depending on the composition of the medium, temperature, etc., but is generally about 1 to 5 days, and the target substance is selectively accumulated at the end of the culture.

培養物から目的とするYL−0710M化合物を採取す
るには微生物の生産する代謝物の培養物から通常用いら
れる抽出1分離、精製の手段が適宜利用される。培養物
中のYL −0710M化合物は培養物そのままか、又
は遠心分離あるいは培養物にr過動剤を加えて濾過して
得ら、れた培養液に酢酸エチル等の水と混和しない有機
溶媒を加えて抽出する。又培養液を適宜の担体に接触さ
せP液中の目的有効成分を吸着させ、ついで適当な溶媒
で溶出する事により目的のYL −0710M化合物を
抽出する事が出来る。さらに詳しく述べるならば9例え
ばダイヤイオンHP −20またはCHP −20Pと
ゆうような多孔性吸着樹脂。
In order to collect the target YL-0710M compound from the culture, extraction, separation, and purification means commonly used from the culture of metabolites produced by microorganisms are appropriately used. The YL-0710M compound in the culture can be obtained from the culture as it is, or by centrifugation or by adding a translucent agent to the culture and filtration, and adding a water-immiscible organic solvent such as ethyl acetate to the culture solution. Add and extract. Further, the desired YL-0710M compound can be extracted by bringing the culture solution into contact with a suitable carrier to adsorb the desired active ingredient in the P solution, and then eluting with a suitable solvent. More specifically, 9 porous adsorption resins such as Diaion HP-20 or CHP-20P.

もしくは例えばダウエクス50.アンバーライトIRC
50というようなイオン交換樹脂に接触させてYL−0
710M化合物を吸着させる。ついで該吸着樹脂の場合
にはメタノール、エタノール。
Or, for example, DOWEX 50. Amber Light IRC
YL-0 by contacting with an ion exchange resin such as 50
Adsorb the 710M compound. Next, in the case of the adsorption resin, methanol and ethanol.

アセトン、アセトニトリル等の有機溶媒と水の混合溶媒
で、該イオン交換樹脂の場合には塩酸。
A mixed solvent of water and an organic solvent such as acetone or acetonitrile, and in the case of the ion exchange resin, hydrochloric acid.

硫酸等の水溶液で溶出させる事によりYL−0710M
化合物含有画分を得る事ができる。
YL-0710M by elution with an aqueous solution such as sulfuric acid.
Compound-containing fractions can be obtained.

酢酸エチル、酢酸ブチル等の有機溶媒で抽出する場合に
は培養r液にこれらの有機溶媒を加え、撹拌して抽出し
た後、得られた抽出液を酸性水で抽出し、ついで該酸性
抽出液を中和した後に、該有機溶媒で再び抽出するとい
う操作を繰り返す事により、 YL−0710M化合物
のより比率の高い両分を得る事ができる。つぎに上記の
各操作法を用いて得られたYL −0710M化合物含
有画分は常用の吸着処理2例えば活性炭。
When extracting with an organic solvent such as ethyl acetate or butyl acetate, add these organic solvents to the culture liquid, stir and extract, and then extract the obtained extract with acidic water. By repeating the operation of neutralizing the compound and then extracting it again with the organic solvent, it is possible to obtain both components of the YL-0710M compound in higher proportions. Next, the YL-0710M compound-containing fraction obtained using each of the above-mentioned operating methods is subjected to a conventional adsorption treatment 2, such as activated carbon.

アルミナ、シリカゲル、セルロース等を担体に用いたカ
ラムクロマトグラフィー、薄層クロマトグラフィー等の
ような常法により分離する事ができる。このように培養
物中に生産されたYL−0710M化合物は遊離塩基の
形、すなわちYL−0710M化合物それ自体として分
離する事ができる。又このYL−0710M化合物遊離
塩基は酸、すなわち例え5ば塩酸、硫酸、燐酸等の無機
酸、又は例えば蟻酸、酢酸、クエン酸、酒石酸、p−ト
ルエンスルホン酸等の有機酸と常法により反応させると
それぞれの酸に対応する塩類にも変化させうる。
Separation can be performed by conventional methods such as column chromatography, thin layer chromatography, etc. using alumina, silica gel, cellulose, etc. as a carrier. The YL-0710M compound thus produced in the culture can be separated as the free base form, ie, the YL-0710M compound itself. The free base of the YL-0710M compound can also be reacted with an acid, such as an inorganic acid such as hydrochloric acid, sulfuric acid, or phosphoric acid, or an organic acid such as formic acid, acetic acid, citric acid, tartaric acid, or p-toluenesulfonic acid, by a conventional method. It can also be converted into salts corresponding to each acid.

(実施例) つぎに実施例を挙げて9本発明をさらに説明する。(Example) Next, the present invention will be further explained with reference to Examples.

実施例 ポテトスターチ3.0%、小麦胚芽1.0%、コプラミ
ール1.0%、フェザ−ミール0.2%、炭酸カルシュ
ラム0.5%を含む培地(pH7,0)を作製し、これ
を500mZ三角フラスコに各60m1スつ分注し、1
20℃で20分間滅菌したものに、ベネット寒天培地上
に良く生育させたスプレブトミセス ニス・ビーYL 
−0710M株の菌糸をかき取って接種し、28℃で4
8時間振盪培養を行ない種培養液とする。つぎにデキス
トリン2.0%、コーンスチープリ力−0.5%、ポリ
ペプトン0.5%、酵母エキス0.5%。
Example A medium (pH 7.0) containing 3.0% potato starch, 1.0% wheat germ, 1.0% copra meal, 0.2% feather meal, and 0.5% calcium carbonate was prepared. Dispense one 60ml volume into each 500mZ Erlenmeyer flask, and
Sprebtomyces Nis bee YL grown well on Bennett agar medium after sterilization at 20°C for 20 minutes
-0710M strain was scraped and inoculated, and incubated at 28℃ for 4 hours.
Culture with shaking for 8 hours and use as a seed culture solution. Next, 2.0% dextrin, 0.5% corn steeple, 0.5% polypeptone, and 0.5% yeast extract.

肉エキス0.3%、プレインハートインフユージョン0
.52%、炭酸カルシーウム0.5%を含む培地(pH
8,0)を106作製し、これを500m1三角フラス
コに各60m1ずつ分注し、120℃で20分間滅菌し
たものに、上記種培養液を3.0%の割合で植菌し。
Meat extract 0.3%, plain heart infusion 0
.. 52%, calcium carbonate 0.5% (pH
8,0) was prepared, 60 ml of each was dispensed into 500 ml Erlenmeyer flasks, sterilized at 120° C. for 20 minutes, and the above seed culture solution was inoculated at a rate of 3.0%.

28℃で96時間培養した。The cells were cultured at 28°C for 96 hours.

このようにして得られた培養液にラジオライト≠600
(昭和化学工業社製)を加えて撹拌した後に沢過し1.
8tの培養液を得た。このF液をpH8,0とし、酢酸
エチルを4tずつ2回に分けて加え撹拌し、抽出した。
Radiolight≠600 was added to the culture solution thus obtained.
(manufactured by Showa Kagaku Kogyo Co., Ltd.) and stirred, then filtered 1.
8 tons of culture solution was obtained. This F solution was adjusted to pH 8.0, and ethyl acetate was added in two portions of 4 tons each, followed by stirring and extraction.

この抽出液を100ntまで減圧濃縮し、  50℃乙
の水を加え、1規定塩酸で水層をpH2,5に調整し、
よく撹拌して目的物を抽出した。
This extract was concentrated under reduced pressure to 100 nt, water at 50°C was added, and the aqueous layer was adjusted to pH 2.5 with 1N hydrochloric acid.
The target product was extracted by stirring well.

この操作を4回繰り返して合計200mZの酸性抽出液
を得た。この酸性抽出液に5On+Zの酢酸エチルを加
え、1規定の苛性ソーダで水層なpH8,0に調整し、
よく撹拌して再抽出した。この操作を4回繰り返して合
計200m1のYL −0710M化合物の酢酸エチル
抽出液を得た。この抽出液に芒硝を加えてよく脱水した
後に芒硝をf過して除去し、F液を減圧濃縮乾固し、2
38■の粗YL−0710M化合物を得た。このように
して得られた粗YL −0710M化合物を外径1.5
cm、長さ100cmのシリカゲル(ワコーゲルC−3
00・和光純薬工業株式会社製)のカラムに付し、酢酸
エチルで展開し、その溶出液を各10gずつフラクショ
ンコレクターで分画した。目的のYL −0710M化
合物はフラクションナンバー6から21の間に溶出され
た。その活性はバチルスズブチリス ATCC6633
株の寒天プレートで検定して確認し、又物質の確認には
シリカゲルプレート(キーゼルゲル60F2り4,20
0mX20cm・メルク社製)を用い、クロロホルム:
メタノール(90:10)の溶媒で展開する薄層クロマ
トグラフィーで目的のYL −0710M化合物(Rt
 = 0.47 )をUVランプ(254nm)で確認
した。
This operation was repeated four times to obtain an acidic extract with a total concentration of 200 mZ. 5On+Z ethyl acetate was added to this acidic extract, and the pH of the aqueous layer was adjusted to 8.0 with 1N caustic soda.
The mixture was thoroughly stirred and re-extracted. This operation was repeated four times to obtain a total of 200 ml of an ethyl acetate extract of the YL-0710M compound. After adding Glauber's salt to this extract and thoroughly dehydrating, the Glauber's salt was removed by filtration, and the F solution was concentrated to dryness under reduced pressure.
38 ml of crude YL-0710M compound was obtained. The crude YL-0710M compound thus obtained was
cm, length 100cm of silica gel (Wakogel C-3
00 (manufactured by Wako Pure Chemical Industries, Ltd.) and developed with ethyl acetate, and the eluate was fractionated in 10 g portions using a fraction collector. The target YL-0710M compound was eluted between fraction numbers 6 and 21. Its activity is Bacillus subtilis ATCC6633
Confirm by assaying on an agar plate of the strain, and use a silica gel plate (Kieselgel 60F2 4,20
Chloroform:
The target YL-0710M compound (Rt
= 0.47) was confirmed using a UV lamp (254 nm).

この溶出画分で割合純度の高いフラクション(フラクシ
ョンナンバー6から14)を集め、減圧濃縮乾固して1
4.OfDgの粗YL−0710M化合物を得た。
Fractions with high relative purity (fraction numbers 6 to 14) were collected from this elution fraction and concentrated to dryness under reduced pressure.
4. Crude YL-0710M compound of OfDg was obtained.

この粗YL−0710M化合物をさらに純粋にするため
にシリカゲルプレート(キーゼルゲル60F254゜2
0 cm X 20 am・メルク社製)の3枚に下か
ら2cm0所に帯状にチャージし、クロロホルム:メタ
ノール(90:10)で15cm展開し、風乾した後に
UVランプ(254nm)でYL −0710M化合物
(Rf = 0.47 )を確認し、この部分をかき取
り、こレヲクロロホルム:メタノール(90: 10)
ノ溶媒を用いて溶出し、その溶出液を減圧濃縮乾固する
事により純粋なYL−0710M化合物を6.0mg得
た。
In order to further purify this crude YL-0710M compound, a silica gel plate (Kieselgel 60F254°2
0 cm x 20 am (manufactured by Merck & Co.) was charged in a strip at 2 cm from the bottom, developed for 15 cm with chloroform:methanol (90:10), air-dried, and then exposed to the YL-0710M compound using a UV lamp (254 nm). (Rf = 0.47), scrape off this part, and add chloroform:methanol (90:10).
The eluate was concentrated to dryness under reduced pressure to obtain 6.0 mg of pure YL-0710M compound.

上記抽出9分離、精製されたYL−0710M化合物遊
離塩基は、下記の物理化学的性質を有する。
The free base of YL-0710M compound separated and purified in the above extraction 9 has the following physicochemical properties.

(1)  色および形状;淡黄色無定形の固体(2)酸
性、中性、塩基性の区別;塩基性(3)溶解性;メタノ
ール、エタノール、アセトン。
(1) Color and shape; pale yellow amorphous solid; (2) Distinction between acidic, neutral, and basic; basic; (3) Solubility; methanol, ethanol, acetone.

酢酸エチル、酢酸フチル、ベンゼン、トルエン。Ethyl acetate, phtyl acetate, benzene, toluene.

クロロホルムには溶けるが水には溶けに<<。It dissolves in chloroform but not in water.

ヘキサンにはほとんど溶けない。Almost insoluble in hexane.

(4)紫外部吸収スペクトル; YL−0710M化合
物の紫外部吸収スペクトルは第1図に示すごとくである
(4) Ultraviolet absorption spectrum; The ultraviolet absorption spectrum of the YL-0710M compound is as shown in FIG.

(5)分子量; 573(M+1)、 595[M十N
a〕(FAB−Mass)(6)  分子式; C29
H4ON4011 (高分解能マススペクトル)(7)
  ctマススペクトル; YL−0710M化合物の
CIマススペクトルは第2図に示すごとくである。
(5) Molecular weight; 573 (M+1), 595 [M1N
a] (FAB-Mass) (6) Molecular formula; C29
H4ON4011 (high resolution mass spectrum) (7)
CT mass spectrum: The CI mass spectrum of the YL-0710M compound is as shown in FIG.

(8)”H−NMRスペクトル; YL−0710M化
合物のI−H−NMRスペクトルは第3図に示すごとく
である。
(8) "H-NMR spectrum; The I-H-NMR spectrum of the YL-0710M compound is as shown in FIG. 3.

(9)  ”−C−N M Rスペクトル; YL−0
710M化合物の13−C−N M Rスペクトルは第
4図に示すごとくである。
(9) “-C-N MR spectrum; YL-0
The 13-C-NMR spectrum of the 710M compound is as shown in FIG.

上記の物理化学的性質からYL −0710M化合物の
構造式は下記のように決定される。
From the above physicochemical properties, the structural formula of the YL-0710M compound is determined as follows.

【図面の簡単な説明】 第1図は、YL−0710M化合物の紫外部吸収スペク
トルを示す。 第2図は、YL−0710M化合物のCIマススペクト
ルを示す。 第3図は、YL−0710M化合物のIH−核磁気共鳴
スペクトルを示す。 第4図&t、 YL−0710M化合物ノl3c−核磁
気共鳴スベクトルを示す。 長井省= 第1図 ・;皮長(nm )
BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 shows the ultraviolet absorption spectrum of the YL-0710M compound. FIG. 2 shows the CI mass spectrum of the YL-0710M compound. FIG. 3 shows the IH-nuclear magnetic resonance spectrum of the YL-0710M compound. FIG. 4 &t shows the nuclear magnetic resonance spectrum of YL-0710M compound. Nagai = Figure 1: Skin length (nm)

Claims (3)

【特許請求の範囲】[Claims] (1)下記平面構造式で示されるYL−0710M化合
物。 ▲数式、化学式、表等があります▼
(1) YL-0710M compound represented by the following planar structural formula. ▲Contains mathematical formulas, chemical formulas, tables, etc.▼
(2)ストレプトミセス属に属するYL−0710M化
合物生産菌を培養し、培養物からYL−0710M化合
物を採取することを特徴とする下記平面構造式で示され
るYL−0710M化合物の製造法。 ▲数式、化学式、表等があります▼
(2) A method for producing a YL-0710M compound represented by the following planar structural formula, which comprises culturing a YL-0710M compound-producing bacterium belonging to the genus Streptomyces and collecting the YL-0710M compound from the culture. ▲Contains mathematical formulas, chemical formulas, tables, etc.▼
(3)YL−0710M化合物生産菌がストレプトミセ
ス エス・ピー(Storeptomyces sp.
)YL−0710M(微工研菌寄第9728号)である
特許請求の範囲第(2)項記載の製造法。
(3) The YL-0710M compound producing bacterium is Streptomyces sp.
) YL-0710M (Feikoken Bibori No. 9728), the manufacturing method according to claim (2).
JP32764487A 1987-12-24 1987-12-24 Yl-0710m compound and production thereof Pending JPH01168660A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP32764487A JPH01168660A (en) 1987-12-24 1987-12-24 Yl-0710m compound and production thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP32764487A JPH01168660A (en) 1987-12-24 1987-12-24 Yl-0710m compound and production thereof

Publications (1)

Publication Number Publication Date
JPH01168660A true JPH01168660A (en) 1989-07-04

Family

ID=18201356

Family Applications (1)

Application Number Title Priority Date Filing Date
JP32764487A Pending JPH01168660A (en) 1987-12-24 1987-12-24 Yl-0710m compound and production thereof

Country Status (1)

Country Link
JP (1) JPH01168660A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130231377A1 (en) * 2010-08-02 2013-09-05 Oregon State University Pactamycin analogs and methods of use
US8957251B2 (en) 2007-04-19 2015-02-17 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Pactamycin analogs and methods of making thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8957251B2 (en) 2007-04-19 2015-02-17 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Pactamycin analogs and methods of making thereof
US9452976B2 (en) 2007-04-19 2016-09-27 Oregon State University Pactamycin analogs and methods of making thereof
US20130231377A1 (en) * 2010-08-02 2013-09-05 Oregon State University Pactamycin analogs and methods of use

Similar Documents

Publication Publication Date Title
JPS6016236B2 (en) Production method of antibiotic C-15003 P-3
KR100230961B1 (en) Novel amimooligosaccharide derivative and process for preparing the same
EP0387712B1 (en) WS 7622 A,B,C and D substances, derivatives thereof, processes for preparation thereof and use thereof
JPH01168660A (en) Yl-0710m compound and production thereof
US4550021A (en) Antitumor antibiotic 81-484 and process for its production
JPH03157372A (en) Yl-01869p substance and production thereof
JP5036554B2 (en) Novel stemphone compounds and process for producing the same
JPH0625095B2 (en) Antibiotic SF-2415 substance and its production method
JPS6348284A (en) Novel antibiotic yp-02908l-a and production thereof
KR810000686B1 (en) Process for the preparation of piperidine derivative
JPS63170392A (en) Scm-127 substance and preparation thereof
JPS59170092A (en) Novel antibiotic, ss8201d and its preparation
JP2786219B2 (en) Y-09194L-B substance and method for producing the substance
JP2795489B2 (en) New substance DC115A compound
JPS62175493A (en) Novel antibiotic yp-02908l-a and production thereof
JPH0398591A (en) New antibiotic substance having antitumor activity and production thereof
JPWO2006095444A1 (en) Stemphones and methods for their production
JPS62186787A (en) Novel microorganism
JPH0259596A (en) Novel substance, utilization and production thereof
JPS63280073A (en) Novel antibiotic yp-02978l-c and production thereof
JPS6344581A (en) Substance yl-0358m-a and production thereof
JPS6230735A (en) Novel antibiotic substance sf-2418 and production thereof
JPS6037991A (en) Antibiotic substance ss8228c and its preparation
JPS62275687A (en) Yp-02259l-a and c substance and production thereof
JPH08208644A (en) New antibiotic substance cremimycin, its production and use